Dr. Feuerstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Anschutz Outpatient Pavilion
1635 Aurora Ct
Aurora, CO 80045Phone+1 720-848-2080
Education & Training
University of ColoradoResidency, Neurology, 2014 - 2018
University of Arizona College of MedicineClass of 2014
Certifications & Licensure
CO State Medical License 2018 - 2025- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis Start of enrollment: 2022 Oct 24
Roles: Contact
Publications & Presentations
PubMed
- 10 citationsSafety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.Andrew McGarry, Shane Rosanbalm, Mika Leinonen, C Warren Olanow, Dennis To
The Lancet. Neurology. 2024-01-01 - 12 citationsClinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review.Laura M Scorr, Hyun Joo Cho, Gamze Kilic-Berkmen, J Lucas McKay, Mark Hallett
Dystonia. 2022-01-01 - 16 citationsCurrent Guidelines for Classifying and Diagnosing Cervical Dystonia: Empirical Evidence and RecommendationsGamze Kilic-Berkmen, Sarah Pirio Richardson, Joel S. Perlmutter, Mark Hallett, Christine Klein
Movement Disorders Clinical Practice. 2021-11-18
Press Mentions
Trial of Weekly, Intense Exercise in Delaying Parkinson’s Starts EnrollingOctober 4th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
